ClinicalTrials.gov
ClinicalTrials.gov Menu

Individualized Treatment Based on Epidermal Growth Factor Receptor Mutations and Level of BRCA1 Expression in Advanced Adenocarcinoma (SLAT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00883480
Recruitment Status : Completed
First Posted : April 17, 2009
Last Update Posted : April 17, 2009
Sponsor:
Information provided by:
Spanish Lung Cancer Group